AGREE II: advancing guideline development, reporting and evaluation in health care. - Wikidata - awgldk - TriplyDB

AGREE II: advancing guideline development, reporting and evaluation in health care.

AGREE II: advancing guideline development, reporting and evaluation in health care.

http://www.wikidata.org/entity/Q34403979

about

Guidance for evidence-informed policies about health systems: rationale for and challenges of guidance development Evaluation of the quality of guidelines for myasthenia gravis with the AGREE II instrument Quaternary Prevention and the Challenges to Develop a Good Practice Comment on "Quaternary Prevention, an Answer of Family Doctors to Overmedicalization"Transparency matters: Kaiser Permanente's National Guideline Program methodological processes Korean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014 Consensus Among International Ethical Guidelines for the Provision of Videoconferencing-Based Mental Health Treatments Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran Development of Quality Management Systems for Clinical Practice Guidelines in Korea Capsule Endoscopy in the Assessment of Obscure Gastrointestinal Bleeding: An Evidence-Based Analysis Actinic Keratosis Clinical Practice Guidelines: An Appraisal of Quality The optimal organization of gynecologic oncology services: a systematic review A critical review of recent clinical practice guidelines on the diagnosis and treatment of non-neurogenic male lower urinary tract symptoms EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice Guideline for primary care management of headache in adults Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines Systematic review of clinical practice guidelines related to multiple sclerosis To what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?A combination of resistance and endurance training increases leg muscle strength in COPD: An evidence-based recommendation based on systematic review with meta-analyses Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators A review of clinical practice guidelines for lung cancer Guidelines for clinical use of CBCT: a review Acute hypertension: a systematic review and appraisal of guidelines Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements Scandinavian guidelines for initial management of minor and moderate head trauma in children.Development methods of guidelines and documents with recommendations on physical restraint reduction in nursing homes: a systematic review.Engaging Older Adults in Health Care Decision-Making: A Realist Synthesis.Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE): 2014 update Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.Health systems guidance appraisal--a critical interpretive synthesis When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelines Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing Inclusion of ethical issues in dementia guidelines: a thematic text analysis Best practices in ranking communicable disease threats: a literature review, 2015.Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3).

P2860

Q21092319-CFD4B91B-4DFF-4C68-9D26-01D39C974A6B Q21131900-AB778C1E-1401-48B7-A836-9FB506C827BC Q24282597-B2AE86EF-DD57-4573-BE7C-0F127D25672F Q24596300-4B9397CD-145F-4AE0-A94A-310F4C55366C Q26739011-1A1995C0-9DBB-47E8-9749-21EB5427A3C9 Q26748599-236C000E-7B05-450F-BD29-D69BFFAB56CE Q26777154-058744AF-1553-4612-9B5E-967291673ED6 Q26779738-C43733E8-02FA-49DC-8539-F943CC3DCC4C Q26781821-621F87E6-7468-4569-9863-AD4F5EC2FFCA Q26785601-359D42F5-B91B-4851-9D78-2888F10420EB Q26795557-4118F5A0-4715-44E6-9BD1-A73EC939FDCE Q26798012-B596D3DC-2E1F-464C-9B72-C5342896D232 Q26798354-B867A829-C88C-443E-853C-DB4D4EC23EE8 Q26798397-DE91C33D-0C77-4A60-A1FB-FC49ED1E5ACD Q26801100-2FE55FBB-6A71-4835-945E-E1B6DBF3B46B Q26822019-2B53D070-B5FE-4B51-B32B-E5C5D91ED85F Q26824425-7732E14D-0EC8-4BCE-AE49-7E2205683A5D Q26828637-DE6EE270-F01F-4214-9755-3F0946F09576 Q26859979-6CE87D7B-FD21-4EFC-9093-DC675AF7CD4B Q26864064-EE7312F4-4E9A-4D9C-8E65-F74936150EB1 Q26999236-A02ADD10-CD25-4B96-8FCD-67C79EF382AB Q27008821-9CE2CB49-8DDA-4BA6-B18C-F00500EE3AFC Q27011845-93050B5E-FB4C-4CA8-93D5-AC9BBE293920 Q27016147-D1402A5B-741D-4B6E-B6F0-E0488E52F3F0 Q27304822-5783F430-F904-4BDE-8CBE-4624ABC0CB9D Q27313239-96E2C23F-AEB2-49EA-BEF0-D89613D51B10 Q27335312-CB15897F-B0D8-4ECE-AA97-0F6360B183E2 Q27348605-86C8A606-E0E3-48CC-BE1C-1258A7F2F430 Q27348844-033C81C3-53C6-460D-98CF-4A57F199654B Q28074115-77DE6B13-824D-489E-AF91-4776FAE03F1A Q28085429-433940DC-6B73-48B9-B70E-B9EBC9EB7A17 Q28385458-2615DB4E-0748-4F1E-A7CF-3DF6B08D883E Q28468439-302FB976-205B-49A3-A09B-2AB30480FB4F Q28534390-DE05E2FD-EE74-4CA9-B6A9-A1BD53FF116D Q28545785-E65AC4A1-8402-4875-8DE2-8E695C6CD9EC Q28553495-25FA5AD1-B279-4389-8472-2D88D8313FB8 Q28682016-4D25A764-5060-4E23-8685-2DF7B5C3C801 Q30152043-D724527E-6AF5-4811-A1B9-1EDC26A4B7D3 Q30203008-CE00F6B6-6009-4ECD-90BC-CE5D6BB45151 Q30244313-2A0D9084-9927-4D3E-892C-12130090D9AA

P2860

AGREE II: advancing guideline development, reporting and evaluation in health care.

http://www.wikidata.org/entity/Q34403979

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

AGREE II: advancing guideline development, reporting and evaluation in health care.

@ast

AGREE II: advancing guideline development, reporting and evaluation in health care.

@en

AGREE II: advancing guideline development, reporting and evaluation in health care.

@nl

type

label

AGREE II: advancing guideline development, reporting and evaluation in health care.

@ast

AGREE II: advancing guideline development, reporting and evaluation in health care.

@en

AGREE II: advancing guideline development, reporting and evaluation in health care.

@nl

prefLabel

AGREE II: advancing guideline development, reporting and evaluation in health care.

@ast

AGREE II: advancing guideline development, reporting and evaluation in health care.

@en

AGREE II: advancing guideline development, reporting and evaluation in health care.

@nl

P1433

Q34403979-8928936B-2323-4A3D-8F97-4778C582D078

P1476

Q34403979-907E1F2E-ABC4-405A-8EDF-B51051995032

P2093

Q34403979-11841320-6D67-478E-8180-929A12FD03F1

Q34403979-4512BC5C-2FA1-4DE1-AC74-4B5037493E63

Q34403979-64E9971F-7348-4317-86C7-F544FA16B2CD

Q34403979-780D8B49-4F89-41E8-A5B5-5DF9A5F7A4A6

Q34403979-81A721EA-F752-4340-B1E5-D5C0D05B161E

Q34403979-A411B756-17EC-4759-A841-3DDF847B226A

Q34403979-BA75CA92-B9DA-422B-8DBB-46A6C7836126

Q34403979-BBAA8659-5ECE-45C8-8A64-6AB0329E8355

Q34403979-C9639D7C-8681-456E-8913-6929659CCC84

Q34403979-FC847E7E-59FB-46EE-924F-7B99B8FC931A

P2860

Q34403979-3067A539-A7AF-4F9D-86DC-9B9716AF3AE2

Q34403979-36508E6B-2394-4D89-89E0-62FD2431EA9D

Q34403979-43FFE345-7751-4E9F-ADBC-D1D1D20C821F

Q34403979-5D25751C-A8B9-41D3-9A2E-9C52A2C374B9

Q34403979-7DB22F09-A227-4439-BF91-DBE1C6876432

Q34403979-7DBF01E2-FA79-48EB-ABBE-76259A5B88EC

Q34403979-9C6D68BE-D81D-401F-BEF4-688E3AEFA95A

Q34403979-E141E48D-E7BA-4F97-BB38-10A981B56937

Q34403979-F9125582-61CC-462D-AC92-D09180F768B6

Q34403979-FE4B54D0-26AC-4E0E-B689-44DB49E2E747

P304

Q34403979-1E8710FF-241E-4E99-985C-D41649878BDA

P31

Q34403979-89E813D8-2118-4EB1-9E51-8054512EE2C9

P356

Q34403979-004C1228-635E-45FB-A594-A99D6376CE2D

P407

Q34403979-8D653B08-7B62-4AF5-B645-96E4EF6CA896

P433

Q34403979-3D2F58E4-C299-4BF5-BD32-7AD02433FC07

P478

Q34403979-16D38758-436F-4664-A02F-721AECF5887D

P50

Q34403979-057364B2-FB37-4B8D-A887-DB10C09CE9AC

Q34403979-392E4615-F496-448D-AF66-F5ACE979AF17

Q34403979-75C1FE39-DE7B-42A4-AF15-20D9BE7A06F7

Q34403979-EF792648-D4F1-418B-94BE-03512B8424A4

Q34403979-F8F67A29-2DB8-49D9-8299-2530C7DEE59B

P577

Q34403979-BAD1DE30-3DC5-4865-AEDD-09266817B044

P698

Q34403979-BD6EB86E-88D5-4045-B440-DE8ADE57AA90

P932

Q34403979-7F0308E9-DA7F-4CF7-9FE2-A6C50D00AF9E

P356

P1433

Canadian Medical Association Journal

P1476

AGREE II: advancing guideline development, reporting and evaluation in health care.

@en

P2093

AGREE Next Steps Consortium

http://www.w3.org/2001/XMLSchema#string

Béatrice Fervers

http://www.w3.org/2001/XMLSchema#string

Francoise Cluzeau

http://www.w3.org/2001/XMLSchema#string

George P Browman

http://www.w3.org/2001/XMLSchema#string

Jako S Burgers

http://www.w3.org/2001/XMLSchema#string

Julie Makarski

http://www.w3.org/2001/XMLSchema#string

Louise Zitzelsberger

http://www.w3.org/2001/XMLSchema#string

Melissa C Brouwers

http://www.w3.org/2001/XMLSchema#string

Peter Littlejohns

http://www.w3.org/2001/XMLSchema#string

Steven E Hanna

http://www.w3.org/2001/XMLSchema#string

P2860

Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature.

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

Development of the AGREE II, part 2: assessment of validity of items and tools to support application.

Rigorous development does not ensure that guidelines are acceptable to a panel of knowledgeable providers.

Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners.

Quality of systematic reviews used in guidelines for oncology practice.

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

P304

E839-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.090449

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P50

Jeremy Grimshaw

Béatrice Fervers

Michelle E. Kho

P577

2010-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20603348

http://www.w3.org/2001/XMLSchema#string

P932

3001530

http://www.w3.org/2001/XMLSchema#string